Intellectual Property Rights

PCB39: Eight hour drafting session charts future course for UNAIDS work program on Intellectual Property and the UN HLP

Posted on by Thiru

The Joint United Nations Programme on HIV/AIDS (UNAIDS) held the 39th Meeting of its Programme Coordinating Board (PCB) from 6-8 December 2016 in Geneva Switzerland. In his opening speech on Tuesday, 6 December 2016, Michel Sidibé (Executive Director, UNAIDS) paid tribute to the life of Australian national Katie Kirk – who passed away on 20 October 2016 while on mission in Indonesia.

In his speech, Sidibé noted:

Continue Reading →

PCB39: Statement of Knowledge Ecology International on Agenda item 6: UNAIDS synthesis report on IP

Posted on by Thiru

On Wednesday, 7 December 2016 Knowledge Ecology International (KEI) delivered the following statement at the 39th session of the UNAIDS Programme Coordinating Board (PCB) during discussions of agenda item 6 entitled, “Synthesis report of existing research and literature on intellectual property-related and other factors impacting the availability, affordability, and accessibility of treatment and diagnostics for HIV and co-infections in low and middle-income countries.”

KEI statement to UNAIDS – PCB 39 – 7 December 2016

Thank you Chair.

Continue Reading →

UNAIDS PCB 39: Statement of India on the Executive Director’s Report to the 39th PCB

Posted on by Thiru

On Tuesday, 6 December 2016, the delegation of India delivered the following intervention at the 39th UNAIDS Programme Coordinating Board (PCB) Meeting.

India declared that she had “recently crossed the milestone of treating 1 million HIV patients with free Anti-Retroviral Therapy (ART).”

I will first briefly share efforts made by India to implement the Fast track Strategy. A number of major policy decisions have been taken recently towards achieving the 90-90-90 targets.

Continue Reading →

9 November 2016 – WTO TRIPS Council – Holy See’s statement on the Report of the UN High-Level Panel on Access to Medicines

Posted on by Thiru

On Wednesday, 9 November 2016, H.E. Archbishop Ivan Jurkovic, (Holy See) delivered the following statement at the World Trade Organization’s (WTO) TRIPS Council’s discussions of the United Nations Secretary-General’s High Level Panel Report on Access to Medicines

Statement by H.E. Archbishop Ivan Jurkovic , Permanent Observer of the Holy See to the United Nations and Other International Organizations in Geneva at the World Trade Organization (WTO) Trade Related Intellectual Property Rights (TRIPs) Council, Geneva, 9 November 2016

Mr. President,

Continue Reading →

9 November 2016 – WTO TRIPS Council – UNCTAD’s statement on the Report of the UN High-Level Panel on Access to Medicines

Posted on by Thiru

On Wednesday, 9 November 2016, the United Nations Conference on Trade and Development (UNCTAD) delivered the following statement at the World Trade Organization’s (WTO) TRIPS Council’s discussions of the United Nations Secretary-General’s High Level Panel Report on Access to Medicines. UNCTAD informed WTO members that the agency had recently recommended to Secretary-General Ban Ki-moon to consider endorsement of the Report of the High Level Panel.

The Report of the United Nations High Level Panel on Access to Medicine
Continue Reading →

9 November 2016 – WTO TRIPS Council – India’s intervention on the Report of the UN High-Level Panel on Access to Medicines

Posted on by Thiru

On Wednesday, 9 November 2016, India delivered the following statement at the World Trade Organization’s (WTO) TRIPS Council’s discussions of the United Nations Secretary-General’s High Level Panel Report on Access to Medicines.

Agenda item 13: the United Nations Secretary-General’s High Level Panel Report on Access to Medicines

Statement by India.

Thank you Chairman.

At the outset, I would like to thank delegations of Brazil, China and South Africa who are also co-sponsors of this agenda item.

Continue Reading →

9 November 2016 – WTO TRIPS Council – WHO’s intervention on the Report of the UN High-Level Panel on Access to Medicines

Posted on by Thiru

On Wednesday, 9 November 2016, the World Health Organization (WHO) delivered the following statement at the World Trade Organization’s (WTO) TRIPS Council’s discussions of the United Nations Secretary-General’s High Level Panel Report on Access to Medicines.

COUNCIL FOR TRIPS

8-9 NOVEMBER 2016

WHO STATEMENT

13. THE UNITED NATIONS SECRETARY-GENERAL’S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES

Thank you very much for giving WHO the opportunity to share our feedback on the Report of the High-Level Panel on Access to Medicines.

Continue Reading →

9 November 2016 – WTO TRIPS Council – Brazil’s intervention on the Report of the UN High-Level Panel on Access to Medicines

Posted on by Thiru

On 9 November 2016, the World Trade Organization’s (WTO) TRIPS Council held discussions on the United Nations Secretary-General’s High-Level Panel Report on Access to Medicines (UN HLP). These timely WTO discussions on the UN HLP germinated from a 27 October 2016 request by Brazil, China, India and South Africa requesting the WTO Secretariat to place a dedicated agenda item for consideration at the 8-9 November 2016 session of the TRIPS Council entitled “the United Nations Secretary-General’s High-Level Panel Report on Access to Medicines.”

Continue Reading →

WTO TRIPS Council – Brazil, China, India and South Africa request discussion of the UN High-Level Panel on Access to Medicines

Posted on by Staff

On Thursday, 27 October 2016, Brazil, China, India and South Africa submitted a communication (IP/C/W/619) to the World Trade Organization (WTO) requesting the WTO Secretariat to “place a dedicated agenda item for consideration at the 8-9 November 2016 session of the TRIPS Council entitled “the United Nations Secretary-General’s High-Level Panel Report on Access to Medicines.” In the WTO submission, Brazil, China, India and South Africa enclosed the entire Final Report of the UN Secretary-General’s High-Level Panel on Access to Continue Reading →